A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer
- 2 November 2004
- journal article
- review article
- Published by Elsevier BV in Mutation research. Reviews in mutation research
- Vol. 555 (1-2), 21-32
- https://doi.org/10.1016/j.mrfmmm.2004.05.017
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Prostate Cancer Prevention by SilibininCurrent Cancer Drug Targets, 2004
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- The development of androgen-independent prostate cancerNature Reviews Cancer, 2001
- Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activationMutation Research, 2001
- Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agentsBiochemical Pharmacology, 2000
- Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1? expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotionMolecular Carcinogenesis, 1999
- DIET, NUTRITION, AND PROSTATE CANCERAnnual Review of Nutrition, 1998
- Hormone resistance in prostate cancer.Cancer and Metastasis Reviews, 1998
- Recent Advances in Chemoprevention of CancerScience, 1997
- Prostate Cancer in Relation to Diet, Physical Activity, and Body Size in Blacks, Whites, and Asians in the United States and CanadaJNCI Journal of the National Cancer Institute, 1995